Noninvasive imaging signatures of HER2 and HR using ADC in invasive breast cancer: repeatability, reproducibility, and association with pathological complete response to neoadjuvant chemotherapy

BACKGROUND: The immunohistochemical test (IHC) of HER2 and HR can provide prognostic information and treatment guidance for invasive breast cancer patients. We aimed to develop noninvasive image signatures IS(HER2) and IS(HR) of HER2 and HR, respectively. We independently evaluate their repeatabilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Xinzhi, Zhang, Jiang, Zhang, Xinyu, Fan, Xinyu, Zhou, Ta, Huang, Yu-hua, Wang, Lu, Lee, Elaine Yuen Phin, Yang, Ruijie, Cai, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308682/
https://www.ncbi.nlm.nih.gov/pubmed/37381020
http://dx.doi.org/10.1186/s13058-023-01674-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308682/
https://www.ncbi.nlm.nih.gov/pubmed/37381020
http://dx.doi.org/10.1186/s13058-023-01674-9

Ejemplares similares